Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma
Open Access
- 1 May 1994
- Vol. 73 (9) , 2352-2358
- https://doi.org/10.1002/1097-0142(19940501)73:9<2352::aid-cncr2820730918>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerHuman Pathology, 1992
- Ductal carcinoma in-situ of the breast; second EORTC consensus meetingEuropean Journal Of Cancer, 1992
- Estrogen receptor immunohistoohemistry in carcinoma in situ of the breastCancer, 1992
- Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive diseaseHuman Pathology, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- DNA ploidy in intraductal breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1990
- Intraductal carcinoma of the breast: Follow-up after biopsy onlyCancer, 1982
- Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 yearsThe American Journal of Surgical Pathology, 1978
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breastCancer, 1978
- Lobular carcinoma in situ of the breast(Long-term followupCancer, 1974